On Tuesday, Spero Therapeutics Inc (NASDAQ: SPRO) opened higher 3.35% from the last session, before settling in for the closing price of $2.09. Price fluctuations for SPRO have ranged from $0.51 to $3.22 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 17.67% over the last five years. Company’s average yearly earnings per share was noted 63.78% at the time writing. With a float of $38.59 million, this company’s outstanding shares have now reached $56.19 million.
Spero Therapeutics Inc (SPRO) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Spero Therapeutics Inc is 31.43%, while institutional ownership is 14.08%. The most recent insider transaction that took place on Aug 28 ’25, was worth 12,947. In this transaction Director of this company sold 6,572 shares at a rate of $1.97, taking the stock ownership to the 703,294 shares. Before that another transaction happened on Aug 28 ’25, when Company’s Chief Operating Officer sold 1,695 for $1.97, making the entire transaction worth $3,339. This insider now owns 739,744 shares in total.
Spero Therapeutics Inc (SPRO) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.32 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.36) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 63.78% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.36% during the next five years compared to 17.67% growth over the previous five years of trading.
Spero Therapeutics Inc (NASDAQ: SPRO) Trading Performance Indicators
Check out the current performance indicators for Spero Therapeutics Inc (SPRO). In the past quarter, the stock posted a quick ratio of 3.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.98, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.04 in one year’s time.
Technical Analysis of Spero Therapeutics Inc (SPRO)
Analysing the last 5-days average volume posted by the [Spero Therapeutics Inc, SPRO], we can find that recorded value of 0.42 million was lower than the volume posted last year of 1.65 million. As of the previous 9 days, the stock’s Stochastic %D was 87.61%.
During the past 100 days, Spero Therapeutics Inc’s (SPRO) raw stochastic average was set at 59.11%, which indicates a significant decrease from 91.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.09 in the past 14 days, which was lower than the 0.13 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.02, while its 200-day Moving Average is $1.50. Now, the first resistance to watch is $2.21. This is followed by the second major resistance level at $2.27. The third major resistance level sits at $2.34. If the price goes on to break the first support level at $2.08, it is likely to go to the next support level at $2.01. Now, if the price goes above the second support level, the third support stands at $1.96.
Spero Therapeutics Inc (NASDAQ: SPRO) Key Stats
There are currently 56,275K shares outstanding in the company with a market cap of 121.56 million. Presently, the company’s annual sales total 47,980 K according to its annual income of -68,570 K. Last quarter, the company’s sales amounted to 14,190 K and its income totaled -1,700 K.
